Author
Number of items: 28.
2013
The development of a 3D immunocompetent model of human skin. (2013)
David Y.S. Chau,
Claire Johnson,
Sheila MacNeil,
John W. Haycock
and
Amir M. Ghaemmaghami
![]()
Improving treatment of stroke through nanotechnology. (2013)
F Nicholls,
N Gorenkova,
Ellen Bible,
C Franco,
David Y.S. Chau,
Christos Tolias,
Kevin Shakesheff,
JL West
and
Michel Modo
2012
Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles. (2012)
Ellen Bible,
Omar Qutachi,
David Y.S. Chau,
Morgan R. Alexander,
Kevin M. Shakesheff
and
Michel Modo
Severe conjunctivochalasis in association with classic type Ehlers-Danlos syndrome. (2012)
John K. Whitaker,
Philip Alexander,
David Y.S. Chau
and
Naing L. Tint
![]()
Tissue transglutaminase (TG-2) modified amniotic membrane : a novel scaffold for biomedical applications. (2012)
David Y.S. Chau,
Sheridan V. Brown,
Melissa L. Mather,
Victoria Hutter,
Naing L. Tint,
Harminder S. Dua,
Felicity R. A. J. Rose
and
Amir M. Ghaemmaghami
![]()
Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype - implications for the role of transglutaminase in coeliac disease. (2012)
William J. Dalleywater,
David Y.S. Chau
and
Amir M. Ghaemmaghami
![]()
2010
Combination of Injectable Multiple Growth Factor-Releasing Scaffolds and Cell Therapy as an Advanced Modality to Enhance Tissue Neovascularization. (2010)
Jaimy Saif,
Theresa M. Schwarz,
David Y.S. Chau,
James Henstock,
Paramjit Sami,
Simon F. Leicht,
Patrick C. Hermann,
Sonia Alcala,
Francisca Mulero,
Kevin M. Shakesheff,
Christopher Heeschen
and
Alexandra Aicher
The visualisation of vitreous using surface modified poly(lactic-co-glycolic acid) microparticles. (2010)
David Y.S. Chau,
Naing L. Tint,
Russell J. Collighan,
Martin Griffin,
Harminder S. Dua,
Kevin M. Shakesheff
and
Felicity R. A. J. Rose
![]()
Laminin and Fibronectin Treatment Leads to Generation of Dendritic Cells with Superior Endocytic Capacity. (2010)
Samuel Garcia-Nieto,
Ramneek K. Johal,
Kevin M. Shakesheff,
Mohamed Emara,
Pierre-Joseph Royer,
David Y.S. Chau,
Farouk Shakib
and
Amir M. Ghaemmaghami
![]()
Transplantation of Human NSCs on VEGF-Releasing Microparticle Scaffolds in a Stroke Model. (2010)
Ellen Bible,
David Y.S. Chau,
M. R. Alexander,
J. Price,
Kevin M. Shakesheff
and
Michel Modo
2009
The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. (2009)
Ellen Bible,
David Y.S. Chau,
Morgan R. Alexander,
Jack Price,
Kevin M. Shakesheff
and
Michel Modo
The effect of delivery via narrow-bore needles on mesenchymal cells. (2009)
Kapil Agashi,
David Y.S. Chau
and
Kevin M. Shakesheff
Attachment of stem cells to scaffold particles for intra-cerebral transplantation. (2009)
Ellen Bible,
David Y.S. Chau,
Morgan R. Alexander,
Jack Price,
Kevin M. Shakesheff
and
Michel Modo
Life support systems for cell therapies. (2009)
K. Agashi,
David Y.S. Chau
and
Kevin M. Shakesheff
2008
In situ gelling hydrogels incorporating microparticles as drug delivery carriers for regenerative medicine. (2008)
Qingpu Hou,
David Y.S. Chau,
Chayanin Pratoomsoot,
Patrick J. Tighe,
Harminder S. Dua,
Kevin M. Shakesheff
and
Felicity R. A. J. Rose
Microparticles as tissue engineering scaffolds : manufacture, modification and manipulation. (2008)
David Y.S. Chau,
K. Agashi
and
K. M. Shakesheff
A novel self-sintering microparticle-based system for regenerative medicine. (2008)
S.Y. Lee,
K. Agashi,
David Y.S. Chau
and
Kevin M. Shakesheff
![]()
A biosynthetic bandage for corneal wound repair. (2008)
Chayanin Pratoomsoot,
Qingpu Hou,
David Y.S. Chau,
H. Tanioka,
K. Hori,
S. Kawasaki,
S. Kinoshita,
Patrick J. Tighe,
Harminder Dua,
Kevin M. Shakesheff
and
Felicity R. A. J. Rose